Hypoglycemic effect of polysaccharides with different molecular weight of Pseudostellaria heterophylla
Tóm tắt
The aims of this study were to evaluate the antidiabetic activity and to detect molecular size of Pseudostellaria heterophylla polysaccharide (PHP). Pseudostellaria heterophylla is a medicine extensively used in traditional Chinese medicine formulas to treat diabetes and its complications. Molecular weight of PHP was determined by gel permeation chromatography combined with phenol-sulphuric acid method and the monosaccharides composition was determined by HPLC with a precolumn derivatization. Four polysaccharides with different molecular weight were compared for hypoglycemic active on two animal models both high does alloxan induced type1 diabetic mellitus (T1DM) and high-fat/lower does streptozotocin induced type2 diabetic mellitus (T2DM). Blood sugar, glucose tolerance, and insulin tolerance were detected. Rat serum IL-1β, IL-2, IL-10, Leptin, TNF-α, Acrp30 and CRP were also analyzed by sandwich-ELISA approaches to preliminary probe the hypoglycemic mechanism of PHP. The hypoglycemic effects related to molecular size of polysaccharide were more effective against T2DM than T1DM. PHP comprise four monosaccharides of galacturonic acid, glucose, galactose and arabinos. T2DM rats daily receiving oral dose of polysaccharide(100 ~ 400 mg/kg) with 50 ~ 210 kDa molecular weight (PF40) could not only significantly lower blood sugar but also reduce total triglyceride level in serum. PF40 improves in insulin tolerance inhibited the expression of some biomarkers including inflammatory cytokine TNF-α and elevated anti-inflammatory cytokine IL-10, regulated adiponectin Acrp30 and leptin. PF40 prevent the cascade of inflammatory events in the treatment of T2DM to block overweight progresses to obesity.
Tài liệu tham khảo
Holst JJ, Vilsb¢II T: Combining GLP-1 receptor agonists with insulin: therapeutic rationales and clinical findings. Diabetes Obes Metab. 2013, 15 (1): 3-14. 10.1111/j.1463-1326.2012.01628.x.
Fang JG, Wei HK, Sun YY, Zhang XD, Liu WY, Chang QT, Wang RH, Gong YW: Regulation of podocalyxin expression in the kidney of streptozotocin-induced diabetic rats with Chinese herbs (Yishen capsule). BMC Complement Altern Med. 2013, 76: 1-6.
Li YJ, Xu HX: Research Progress on Anti · diabetic Chinese Medicines. Zhong Yao Cai. 2006, 29 (6): 621-625.
Grant SJ, Chang DHT, Liu JX, Wong V, Kiat H, Bensoussan A: Chinese herbal medicine for impaired glucose tolerance: a randomized placebo controlled trial. BMC Complement Altern Med. 2013, 104: 1-8.
Teugwa CM, Boudjeko T, Tchinda BT, Mejiato PC, Zofou D: Anti-hyperglycaemic globulins from selected Cucurbitaceae seeds used as antidiabetic medicinal plants in Africa. BMC Complement Altern Med. 2013, 63: 1-7.
Guo XY, Yoshitomi H, Gao M, Qin LL, Duan Y, Sun W, Xu TH, Xie PF, Zhou JX, Huang LS, Liu TH: Guava leaf extracts promote glucose metabolism in SHRSP.Z-Leprfa/Izm rats by improving insulin resistance in skeletal muscle. BMC Complement Altern Med. 2013, 52: 1-8.
Pierre W, Gildas AJH, Ulrich MC, Modeste W-N, Benoît NT, Albert K: Hypoglycemic and hypolipidemic effects of Bersama engleriana leaves in nicotinamide/streptozotocin-induced type 2 diabetic rats. BMC Complement Altern Med. 2012, 264: 1-6.
Manya K, Champion B, Dunning T: The use of complementary and alternative medicine among people living with diabetes in Sydney. BMC Complement Altern Med. 2012, 2: 1-5.
Jiang ZS, Ni Q, Zhou XZ, Xing WJ, Ling L, Liu BY: Study on drug law of Type 2 diabetes based on structured clinical information acquisition system. J Shandong University of TCM. 2007, 31 (3): 159-203.
Chen WN, Jiang M, Zheng G, Guo HT, Zhou Q, Lv AP: Exploring rules of Chinese patent medicines and Western medicines in treatment of type 2 diabetes with text mining. Chinese J Exp Tradit Med Formulae. 2011, 17 (21): 299-302.
Ni Q, Chen SB, Zhou XZ, Wei ZX, Gao YB, Li Y, Wang XM, Li P, Lin L, Liu BY: Study of relationship between formula (herbs) and syndrome about Type 2 diabetes mellitus affiliated metabolic syndrome based on free-scale networks. Chinese Journal of Information on TCM. 2006, 13 (11): 19-22.
Liu M, Wu K, Mao XQ, Wu Y, Ouyang JP: Astragalus polysaccharide improves insulin sensitivity in KKAy mice: Regulation of PKB/GLUT4 signaling in skeletal muscle. J Ethnopharmacol. 2010, 127 (1): 32-37. 10.1016/j.jep.2009.09.055.
Li WL, Zheng HC, Bukuru J, De-Kimpe N: Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J Ethnopharmacol. 2004, 92 (1): 1-21. 10.1016/j.jep.2003.12.031.
Chan CH, Ngoh GC, Yusoff R: Brief review on anti diabetic plants: Global distribution, active ingredients, extraction techniques and acting mechanisms. Pharmacogn Rev. 2012, 6 (11): 22-28. 10.4103/0973-7847.95854.
Commission P: Pharmacopoeia of the People’s Republic of China; Medical Science and Technology Press: Beijing. China. 2010, 1: 62-63.
Pang WS, Lin SD, Dai QW, Zhang HC, Hu J: Antitussive activity of pseudostellaria heterophylla (Miq.) pax extracts and improvement in lung function via adjustment of multi-cytokine levels. Molecules. 2011, 16 (4): 3360-3370.
Xia LZ, Xu XX, Zhang R: Efects of Pseudostellaria Polysaccharides on Glucose and Lipid Metabolism in Diabetic Rats. China Pharmaceuticals. 2009, l8: 17-18.
Ni SD, Xia LZ, Xu XX, Zhang R: Efect of pseudostellaria polysaccharides in diabetic mice by alloxan. Anhui Medical and Pharmaceutical. 2010, 14 (5): 521-522.
Xu JL, Xu AR, Ying JY, Ma WC, Chen YN: Effect of Pseudostellaria Polysaccharides on Glucose and Insulin Metabolism on Diabetic Rats. Chinese Arch Tradit Chinese Medicine. 2012, 30 (2): 423-424.
Badawi A, Klip A, Haddad P, Cole DEC, Garcia BB, El-Sohemy A, Karmali M: Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention. Diabetes, Metab Syndr Obes. 2010, 3: 173-186.
Li YK, Jin RM, Wang QM: Experimental Methodology of TCM Pharmacology. 2006, Shanghai, China: Shanghai Science and Technology Press, 603-607.
Ankur R, Shahjad A: Alloxan induced diabetes: mechanisms and effects. Int J Res Pharm Biomed Sci. 2012, 3 (2): 819-823.
Duseja A, Thumburu KK, Das A, Dhiman RK, Chawla YK, Bhadada S, Bhansali A: Insulin tolerance test is comparable to homeostasis model assessment for insulin resistance in patients with nonalcoholic fatty liver disease. Indian J Gastroenterol. 2007, 26 (4): 170-173.
Marianne BS, Jeffrey T, Géraldine P, Lorella M, Jan AE, Julie KC, Francois P, Philippe AH, Gordon CW, Marc YD: Increased Interleukin (IL)-1β Messenger Ribonucleic Acid Expression in β-Cells of Individuals with Type 2 Diabetes and Regulation of IL-1β in Human Islets by Glucose and Autostimulation. Clin Endocrinol Metab. 2008, 93 (10): 4065-4074. 10.1210/jc.2008-0396.
Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001, 7: 941-946. 10.1038/90984.
Ravipati S, Rajkuma B: Role of Leptin in Diabetes Mellitus. Indian J Fundam Appl Life Sci. 2011, 1 (2): 209-214.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/13/267/prepub